Sign inJoin waitlistJoin the waitlist

Terrence Bradley

Associate Professor of Clinical Medicine, Hematology · University of Miami/Jackson Health System

Credentials: · · · · · ·

History

University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present

Hematology and Medical Oncology
Jackson Memorial Hospital
2015–2018
North Shore University Hospital - Northwell Health
2012–2015
SUNY Downstate University Health Sciences University College of Medicine
2008–2012

Research

Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study
Journal of Clinical Oncology · 2023 · 173 citations
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Journal of Clinical Oncology · 2022 · 173 citations
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results
Journal of Clinical Oncology · 2023 · 126 citations

Justin Watts
15 papers
Justin Taylor
6 papers
DS
David Sallman
5 papers
Mikkael Sekeres
5 papers
RK
Rami Komrokji
5 papers
SI
Sunil Iyer
5 papers · 3 as a fellow
Eunice Wang
4 papers
Namrata Chandhok
4 papers · 1 as a fellow
Naval Daver
4 papers
RR
Raajit Rampal
4 papers
RS
Ronan Swords
4 papers
Adam Asch
3 papers

Clinical trials

Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Principal investigator · Recruiting · Phase 1
Terrence J Bradley, MD
2022–2026
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
Principal investigator · Active not recruiting · Phase 2
Terrence J Bradley, MD
2020–2027
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2027